What does CUSIP 015117B10 represent in this 13F holders report?

CUSIP 015117B10 is the security identifier for 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM used to aggregate holder disclosures.

How many institutions held 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in Q2 2015?

1 institutional investor reported 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM for Q2 2015. Use the holders table for investor-level position and value details.

CELLDEX THERAPEUTICS INC NEW - COM

CUSIP: 015117B10

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / COM
Total 13F shares: 16,040
Share change: +16,040
Total reported value: $405,000
Price per share: $25.25
Number of holders: 1
Value change: +$405,000
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 015117B10?
CUSIP 015117B10 identifies 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q2 2014

Recent filing periods for CUSIP 015117B10:

Q4 2016 Q3 2016 Q3 2015 Q2 2015 Q2 2014 Q1 2014 Q4 2013

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM as of Q2 2015

As of 30 Jun 2015, CELLDEX THERAPEUTICS INC NEW - COM was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 16,040 shares. The largest 1 holders included NORTHERN TRUST CORP. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.